Morgan Stanley’s Biote Corp BTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BTMD
3C
BP
RHJA
Morgan Stanley's BTMD Position: Q2 2026 in Review
Morgan Stanley reduced its Biote Corp (BTMD) stake by 18% in Q2 2026, selling an estimated $70.7K and leaving 153,907 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #5791.
Morgan Stanley first reported a position in BTMD in Q2 2022 and has held it in 16 quarters since. The position peaked at $887K in Q2 2025. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.
- Morgan Stanley held 153,907 shares of Biote Corp worth $291K as of Q2 2026.
- Morgan Stanley sold 34,293 Biote Corp shares in Q2 2026, an estimated $70.7K.
- Biote Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5791 holding.
- Morgan Stanley first reported a position in Biote Corp in Q2 2022 and has held it in 16 quarters since.
- Morgan Stanley's Biote Corp position peaked at $887K in Q2 2025.
- 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.